Apellis Pharmaceuticals
APLS
#3551
Rank
S$3.76 B
Marketcap
$30.01
Share price
-2.09%
Change (1 day)
-60.90%
Change (1 year)

EPS for Apellis Pharmaceuticals (APLS)

EPS in 2023 (TTM): -$7.06

According to Apellis Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$7.00. In 2022 the company made an earnings per share (EPS) of -$8.17 an increase over its 2021 EPS that were of -$11.79.

EPS history for Apellis Pharmaceuticals from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$7.06-13.53%
2022-$8.17-30.73%
2021-$11.7992.81%
2020-$6.12-11.73%
2019-$6.93123.18%
2018-$3.1127.08%
2017-$2.44

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.91-58.48%๐Ÿ‡บ๐Ÿ‡ธ USA